Oppenheimer Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.44M Sell
19,920
-806
-4% -$149K 0.04% 424
2025
Q4
$4.13M Sell
20,726
-1,979
-9% -$359K 0.05% 338
2025
Q3
$3.55M Sell
22,705
-642
-3% -$102K 0.04% 415
2025
Q2
$3.54M Sell
23,347
-14,229
-38% -$1.9M 0.04% 403
2025
Q1
$5.66M Buy
37,576
+4,671
+14% +$783K 0.07% 290
2024
Q4
$6.07M Sell
32,905
-13,651
-29% -$2.63M 0.07% 284
2024
Q3
$9.17M Sell
46,556
-989
-2% -$206K 0.11% 207
2024
Q2
$9.82M Buy
47,545
+4,231
+10% +$959K 0.13% 191
2024
Q1
$11.7M Sell
43,314
-1,034
-2% -$247K 0.17% 147
2023
Q4
$10.5M Sell
44,348
-3,690
-8% -$726K 0.15% 172
2023
Q3
$9.41M Sell
48,038
-752
-2% -$154K 0.14% 171
2023
Q2
$10.3M Buy
48,790
+1,896
+4% +$377K 0.15% 169
2023
Q1
$9.46M Buy
46,894
+5,041
+12% +$1.14M 0.15% 170
2022
Q4
$9.12M Sell
41,853
-229
-0.5% -$50K 0.15% 178
2022
Q3
$8.28M Buy
42,082
+6,447
+18% +$1.39M 0.15% 174
2022
Q2
$7.63M Sell
35,635
-383
-1% -$93.6K 0.13% 195
2022
Q1
$10.2M Buy
36,018
+8,367
+30% +$2.58M 0.15% 171
2021
Q4
$10.4M Buy
27,651
+1,386
+5% +$538K 0.14% 179
2021
Q3
$10.8M Sell
26,265
-2,098
-7% -$871K 0.15% 155
2021
Q2
$10.5M Buy
28,363
+565
+2% +$189K 0.15% 164
2021
Q1
$8.06M Buy
27,798
+11,190
+67% +$3.11M 0.12% 194
2020
Q4
$4.15M Sell
16,608
-475
-3% -$113K 0.07% 310
2020
Q3
$3.87M Sell
17,083
-3,704
-18% -$769K 0.08% 295
2020
Q2
$3.62M Buy
20,787
+2,047
+11% +$327K 0.07% 288
2020
Q1
$2.37M Sell
18,740
-61
-0.3% -$9.15K 0.06% 315
2019
Q4
$2.87M Buy
18,801
+274
+1% +$37.9K 0.06% 327
2019
Q3
$2.45M Sell
18,527
-8
-0% -$1.07K 0.05% 355
2019
Q2
$2.63M Buy
18,535
+1,218
+7% +$165K 0.06% 339
2019
Q1
$2.52M Sell
17,317
-396
-2% -$52K 0.06% 345
2018
Q4
$2M Buy
17,713
+9
+0.1% +$1.13K 0.05% 367
2018
Q3
$2.38M Sell
17,704
-195
-1% -$24.1K 0.05% 371
2018
Q2
$2.01M Sell
17,899
-3,002
-14% -$325K 0.05% 398
2018
Q1
$2.23M Buy
20,901
+1,741
+9% +$188K 0.06% 355
2017
Q4
$2.07M Hold
19,160
0.05% 368
2017
Q3
$2.07M Buy
19,160
+9,415
+97% +$967K 0.05% 370
2017
Q2
$985K Buy
9,745
+4,804
+97% +$442K 0.03% 587
2017
Q1
$444K Buy
+4,941
New +$420K 0.01% 817

Other funds holding CRL